Clinical Trial: A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Mild Hypertension
Study Type: INTERVENTIONAL
Official Title: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered QCZ484
Brief Summary:
This is a randomized, double-blind, placebo-controlled study including Part A single ascending dose (SAD) in healthy subjects and Part B single dose in subjects with mild hypertension.
Read more